 WATERTOWN, Mass., Nov. 11, 2021 PRNewswire -- Lyra Therapeutics, Inc. Nasdaq: LYRA, a clinical-stage therapeutics company leveraging its proprietary XTreoTM platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat ENT passages and other diseased tissues, today announced that Maria Palasis, Ph.D. 